Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy

BMC Cancer

Table 1 The relationship between clinicolpathological factors and periampullary adenocarcinoma

Characteristic		N	Periampullary adenocarcinoma			P
Characteristic		N	Panceatic head adenocarcinoma	Duodenal adenocarcinoma	Ampullary adenocarcinoma	P
Total		205	67	15	123
Age	< 60	127	38	10	79	0.551
Age	≥ 60	78	29	5	44	0.551
Gender	Male	128	41	12	75	0.345
Gender	Female	77	26	3	48	0.345
WBC (× 10⁹/L)	< 10	172	58	13	101	0.695
WBC (× 10⁹/L)	≥ 10	33	9	2	22	0.695
CRP (mg/L)	< 8	58	27	4	27	0.027
CRP (mg/L)	≥ 8	147	40	11	96	0.027
ALT (U/L)	< 40	79	48	5	26	0.455
ALT (U/L)	≥ 40	156	49	10	97	0.455
AST (U/L)	< 45	47	20	6	21	0.035
AST (U/L)	≥ 45	158	47	9	102	0.035
ALB (g/L)	< 35	52	11	3	38	0.080
ALB (g/L)	≥ 35	153	56	12	85	0.080
TBIL (mmol/L)	< 20.5	38	18	4	16	0.045
TBIL (mmol/L)	≥ 20.5	167	49	11	107	0.045
ALP (U/L)	< 100	31	16	4	11	0.010
ALP (U/L)	≥ 100	174	51	11	112	0.010
GGT (U/L)	< 50	25	15	4	6	< 0.001
GGT (U/L)	≥ 50	180	52	11	117	< 0.001
Tumor differentiation	W	5	0	1	4	0.463
	W-M	8	4	0	4
	M	108	31	7	70
	M-P	63	23	6	34
	P	21	9	1	11
Tumor diameter (cm)	< 2	69	14	2	53	0.002
Tumor diameter (cm)	≥ 2	136	53	13	70	0.002
LNR	< 0.17	151	50	12	89	0.798
LNR	≥ 0.17	54	17	3	34	0.798
LN metastasis	Absent	116	36	9	71	0.836
LN metastasis	Present	89	31	6	52	0.836
Chemotherapy	No	87	28	7	52	0.941
Chemotherapy	Yes	118	39	8	71	0.941

WBC white blood cell count, CRP C-reactive protein, ALT alanine transaminase, AST aspartate aminotransferase, ALB albumin, TBIL total bilirubin, ALP alkaline phosphatase, GGT gamma-glutamyl transpeptidase, W well, M moderate, P poor, W-M well-moderate, M-P moderate-poor, LN lymph node

ISSN: 1471-2407